Active ingredient
Recombinant Neisseria Meningitidis Group B Nada Protein
1 medication authorised for sale in Canada contains Recombinant Neisseria Meningitidis Group B Nada Protein.
How it is classified
- Anti-infectives for systemic use
The anatomical main group records the body system a medicine acts on. It is not a statement of what this ingredient treats, and nothing on this page is.
Products containing Recombinant Neisseria Meningitidis Group B Nada Protein
Strengths and forms differ between these products — check them against your own. Containing the same active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.
This is the only medication in Canada containing Recombinant Neisseria Meningitidis Group B Nada Protein.
Only one authorised product in Canada contains this ingredient, so this page and that product’s page describe the same thing. That usually means no generic version has been authorised — not that alternatives were hidden.
Source: Health Canada — Drug Product Database. Data current as of 2026-08-12. Marketed human products only.